Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

Significance of Serum 8-Hydroxydeoxyguanosine Levels to the Intima-Media Thickness of the Carotid Artery in Type 2 Diabetes

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

Assessments of Correlation Between Intima-Media Thickness and Elasticity of Carotid in Patients with Type 2 Diabetes Accompanied Hyperlipidemia

Relationship of Carotid Intima-media Thickness with Serum High Sensitive C-reactive Protein and Insulin Resistance Risk Factors in Type 2 Diabetes Mellitus

Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes.

Association between serum 25-hydroxy vitamin D level and carotid intima-media thickness in patients with type 2 diabetes

Different variations of serum 25 - hydroxyvitamin D levels in patients with type 2 diabetes and its correlation with carotid intima - media thickness

Association of Serum Leptin with Intima-Media Thickness of Carotid Artery in Type 2 Diabetes Patients

Serum Metabolic Signatures of Subclinical Atherosclerosis in Patients with Type 2 Diabetes Mellitus: a Preliminary Study

Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes

Study of Carotic Intima-Media Thickness and Risk Factors in Patients with Type 2 Diabetes Mellitus

Association between glycated hemoglobin and carotid intima-media thickness in newly diagnosed type 2 diabetes patients

High Sensitivity C-reactive Protein is Associated with Carotid Intimal Medial Thickness in Type 2 Diabetes Mellitus

Impact of Increased Serum 8-Hydroxy-2′-deoxyguanosine Levels on Extent of Coronary Artery Lesions in Elderly Patients with Type 2 Diabetes

Long-term intensive glycemic and lipid control ameliorates the carotid intima medial thickness in type 2 diabetes mellitus

Correlation Between Glucose Fluctuations and Carotid Intima-Media Thickness in Type 2 Diabetes.

Relationship between plasma fibrinogen level and intima-media thickness of carotid artery in type 2 diabetes mellitus patients

Study on carotid intima-media thickness and stiffness in type 2 diabetic patients

Carotid intima-media thickness and stiffness in relation to type 2 diabetes in Chinese

Carotid Arterial Intima-Media Thickness in Subjects with Normal Urinary Albumin Excretion at Different Status of Glucose Tolerance

Hyperglycaemia after Glucose Loading is A Major Predictor of Preclinical Atherosclerosis in Nondiabetic Subjects